In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law Orthopedic Use of BPC 157 Sports Med Review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University